|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00487877 |
|
Date of registration:
|
18/06/2007 |
|
Primary sponsor: |
|
|
Public title:
|
Measurements of Skin Physiological Parameters as Mean of Metabolic Assessment
TEMP |
|
Scientific title:
|
Measurements of Skin Physiological Parameters as Mean of Metabolic Assessment |
|
Date of first enrolment:
|
June 2007 |
|
Target sample size:
|
40 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00487877 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
|
|
|
Countries of recruitment
|
|
Israel
| | | | | | | |
|
Contacts
|
|
Name:
|
Nachum Vaisman, Prof. |
|
Address:
|
|
|
Telephone:
|
+972-524-266-596 |
|
Email:
|
vaisman@tasmc.health.gov.il |
|
Affiliation:
|
|
|
|
Name:
|
Nachum Vaisman, Prof. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
|
|
Name:
|
Nachum Vaisman, Prof. |
|
Address:
|
|
|
Telephone:
|
+972-524-266-596 |
|
Email:
|
vaisman@tasmc.health.gov.il |
|
Affiliation:
|
|
|
|
Name:
|
Nachum Vaisman, Prof. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
unaffiliation |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. Over 18 years old
2. BMI: 22-30 Kg / m2
Exclusion Criteria:
1. Any unbalanced chronic disease
2. Any infection disease
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Hungry-Satiation Situation
|
|
Intervention(s)
|
|
Device: i-button DS2191 H
|
|
Device: SenseWear Pro3 Armband
|
|
Secondary ID(s)
|
|
TASMC-06-NV-380-CTIL
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|